Skip to main content

Month: August 2023

Lerøy Seafood Group ASA: Invitation to presentation of results for Q2 2023

Lerøy Seafood Group ASA will present its results for Q2 2023 on 23 August 2023 at Scandic Flesland Airport hotel in Bergen at 08:45 CET during the event “Vestland på Børs”. The presentation will be held in Norwegian followed by a Q&A session. You may alternatively follow the Norwegian presentation and submit questions through a live broadcast available on https://www.leroyseafood.com/no/investor/. The quarterly report and presentation will be published at 06:30 CET. A recording of the presentation in English will be available from 14:00 CET on https://www.leroyseafood.com/no/investor/. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.

Continue reading

Commercial Vehicle Rental and Leasing Market to Surpass 149.47 Billion by 2030 Drives Due to Business Flexibility and Cost Efficiency

SkyQuest projects that the commercial vehicle rental and leasing market will attain a USD 149.47 billion value by 2030, with a CAGR of 6.8% over the forecast period (2023-2030). The commercial vehicle rental and leasing market grows as businesses seek flexible transportation solutions without long-term commitments. Rental and leasing options offer cost-effective alternatives to maintaining commercial vehicles, enabling companies to manage fleet size as per demand fluctuations. Westford, USA, Aug. 15, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, growth in e-commerce and logistics activities propels demand within the commercial vehicle rental and leasing market. Rental and leasing services offer adaptable and specialized solutions to cater to the rising need for freight transport and last-mile deliveries, aligning with the industry’s...

Continue reading

Constellation Software Inc. Announces Declaration of Warrant Dividend

TORONTO, Aug. 15, 2023 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX: CSU) (the “Company”) announced today that it has resolved to pay a special dividend (the “Warrant Dividend”), pursuant to which all common shareholders of record on August 24, 2023 (the “Record Date”) will be entitled to receive, by way of a dividend-in-kind, one warrant of the Company (collectively, the “Warrants”) for each common share of the Company (the “Common Shares”) held. More information about the features of the Warrants are included below. The payment date for the Warrant Dividend is expected to be on or about August 29, 2023. The Common Shares will commence trading on an ex-dividend basis at the opening of markets on August 23, 2023. Separately, the Company has recently announced its intention to issue up to an additional C$700 million aggregate...

Continue reading

TOFUTTI ANNOUNCES RESULTS FOR THIRTEEN AND TWENTY-SIX WEEKS ENDED JULY 1, 2023

Cranford, New Jersey, Aug. 15, 2023 (GLOBE NEWSWIRE) — TOFUTTI BRANDS INC. (OTCQX Symbol: TOFB) issued its results for the thirteen and twenty-six weeks ended July 1, 2023 today. Tofutti Brands reported net sales for the thirteen weeks ended July 1, 2023 decreased by $260,000, or 9%, to $2,719,000, from net sales of $2,979,000 for the thirteen weeks ended July 2, 2022. Sales of our vegan cheese products decreased to $2,283,000 for the thirteen weeks ended July 1, 2023 from $2,526,000 for the thirteen weeks ended July 2, 2022. Sales of our frozen dessert products decreased to $436,000 in the thirteen weeks ended July 1, 2023 from $453,000 for the thirteen weeks ended July 2, 2022. For the twenty-six week period ended July 1, 2023, sales decreased by $1,234,000 or 19% to $5,208,000 compared to $6,442,000 for the twenty-six week...

Continue reading

Hereditary Angioedema Treatment Market Set to Soar Past USD 10.39 Billion by 2030

The global Hereditary Angioedema Treatment market size is expected to reach USD 10.39 billion by 2030 and exhibit a CAGR of 2.56% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing prevalence of hereditary angioedema, advancements in treatment options, growing awareness and diagnosis rates, rising demand for effective therapies, improving healthcare infrastructure, and favorable reimbursement policies fuel the market’s growth. Westford USA, Aug. 15, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Hereditary Angioedema Treatment market, increasing focus on targeted therapies, adoption of long-acting prophylactic treatments, development of novel therapeutic approaches, growing use of self-administered treatments, expansion of treatment...

Continue reading

Hi-View Closes Shares For Debt Transaction

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 15, 2023 (GLOBE NEWSWIRE) — Hi-View Resources Inc. (“Hi-View” or the “Company”’) (CSE: “HVW”; FSE:”B63” ) announces today that further to its news release of August 3, 2023, the Company has completed a shares-for-debt transaction (the “Debt Settlement Transaction”) with 3 arm’s length creditors of the Company’s subsidiary Zeal Exploration Inc. (“Zeal”), pursuant to which the Company has settled on behalf of Zeal $28,750 of indebtedness through the issuance of an aggregate of 287,500 common shares in the capital of the Company at a deemed price of $0.10 per common share. The common shares issued pursuant to the Debt Settlement Transaction are subject to a four month plus one day hold...

Continue reading

Brown & Brown, Inc. to host Investor Day

DAYTONA BEACH, Fla., Aug. 15, 2023 (GLOBE NEWSWIRE) — Brown & Brown, Inc. (NYSE: BRO) will host an Investor Day on Thursday, September 14, 2023, at Brown & Brown’s Beach Street Campus in Daytona Beach, Florida. The event will feature presentations and a question-and-answer session with J. Powell Brown, Brown & Brown’s president and chief executive officer, and R. Andrew Watts, Brown & Brown’s executive vice president and chief financial officer, and other members of the Company’s senior leadership team. The event is scheduled to begin at 8:00 a.m. EDT and will continue until approximately 12:30 p.m. EDT. Due to limited capacity, in-person attendance is limited to institutional investors and financial analysts. The Company is also offering a live webcast on Brown & Brown’s website beginning at 8:00...

Continue reading

MediciNova Receives a New Patent Covering MN-001 for the Treatment of Scleroderma and Systemic Sclerosis in Europe

LA JOLLA, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it has received a Decision to Grant from the European Patent Office for a new patent which covers MN-001 (tipelukast) for the treatment of scleroderma and/or systemic sclerosis. This patent is expected to expire no earlier than June 2035. The allowed claims cover the use of MN-001 (tipelukast) for inhibiting or treating scleroderma and/or systemic sclerosis. The allowed claims cover oral administration, including tablets and capsules, as well as liquid dosage forms. The allowed claims cover a wide range of doses and a range of different dosing frequencies. Kazuko Matsuda, M.D. Ph.D., MPH., Chief Medical...

Continue reading

Gallant Capital Partners Invests in Cybersecurity Firms DynTek and rSolutions to Support Growth and Innovation

Paul Kerr appointed as CEO of both companies IRVINE, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) — Gallant Capital Partners (“Gallant”), a Los Angeles-based investment firm, announced that it has completed a strategic growth investment in DynTek, Inc. (“DynTek”), a US-based professional IT services, cybersecurity, and risk management organization, and rSolutions Corporation (“rSolutions”), a Canadian-based cybersecurity firm. Gallant’s investment in both companies will support accretive growth through further innovation and development of technical offerings and cybersecurity services, operational enhancements that drive customer experience, and strategic acquisitions. Gallant’s investment was made in partnership with DynTek CEO Tim Montgomery, rSolutions CEO Richard Baker, and additional sellers and members of both executive leadership...

Continue reading

Ceylon Graphite Announces Completion of Annual Filings

VANCOUVER, British Columbia, Aug. 15, 2023 (GLOBE NEWSWIRE) — Ceylon Graphite Corp. (“Ceylon” or the “Company”) (TSX-V: CYL) (OTC: CYLYF) (FSE: CCY) announces today that, further to the Company’s press release dated August 1, 2023, the Company’s audited financial statements and management discussion and analysis (the “Annual Filings”) for the year ended March 31, 2023 have now been released and filed under the Company’s profile on www.sedarplus.ca. While the preparation of the Annual Filings took longer than expected, the Company does not anticipate such delays with future filings. About Ceylon Graphite Corp. Ceylon is a public company listed on the TSX Venture Exchange, that is in the business of mining for graphite, and developing and commercializing innovative graphene and graphite applications and products. Graphite...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.